Cargando…
Extramedullary Manifestation in Multiple Myeloma Bears High Incidence of Poor Cytogenetic Aberration and Novel Agents Resistance
Extramedullary disease (EMD) in multiple myeloma (MM) patients is an uncommon event and more attention was directed toward the feature of these patients. Cytogenetic aberration is an important characteristic of MM and is associated with patients' outcome. In this study, we aimed to compare the...
Autores principales: | Qu, Xiaoyan, Chen, Lijuan, Qiu, Hairong, Lu, Hua, Wu, Hanxin, Qiu, Hongxia, Liu, Peng, Guo, Rui, Li, Jianyong |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hindawi Publishing Corporation
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4423005/ https://www.ncbi.nlm.nih.gov/pubmed/25984534 http://dx.doi.org/10.1155/2015/787809 |
Ejemplares similares
-
Clinical features of multiple myeloma patients with isolated extramedullary relapse
por: Qu, Xiaoyan, et al.
Publicado: (2018) -
Characteristics and prognostic value of extramedullary chromosomal abnormalities in extramedullary myeloma
por: Xia, Yuan, et al.
Publicado: (2022) -
The amplification of 1q21 is an adverse prognostic factor in patients with multiple myeloma in a Chinese population
por: Yu, Wenjun, et al.
Publicado: (2016) -
Advances in the treatment of extramedullary disease in multiple myeloma
por: Li, Yating, et al.
Publicado: (2022) -
Multiple Extramedullary-Bone Related and/or Extramedullary Extraosseous Are Independent Poor Prognostic Factors in Patients With Newly Diagnosed Multiple Myeloma
por: He, JingSong, et al.
Publicado: (2021)